AnaptysBio Ownership 2024 | Who Owns AnaptysBio Now?


OverviewForecastRevenueFinancialsChart

Institutional Ownership

108.79%

Insider Ownership

1.75%

Retail Ownership

-10.54%

Institutional Holders

136.00

AnaptysBio Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ECOR1 CAPITAL, LLC27.49%5.77%7,521,024--188,476,861Jun 30, 2024
FMR LLC10.49%0.00%2,870,6182,729,8721939.57%71,937,692Jun 30, 2024
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.7.92%2.54%2,165,5911,265,891140.70%54,269,710Jun 30, 2024
BLACKROCK INC.6.47%0.00%1,769,94449,8932.90%44,354,795Jun 30, 2024
VANGUARD GROUP INC5.21%0.00%1,424,40670,4035.20%35,695,615Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC4.87%3.40%1,330,879--33,351,828Jun 30, 2024
BOXER CAPITAL, LLC4.75%1.72%1,300,000--32,578,000Jun 30, 2024
STATE STREET CORP3.53%0.00%966,852-240,552-19.92%24,229,311,000Jun 30, 2024
PALO ALTO INVESTORS LP2.94%2.33%803,6413,7350.47%20,139,243Jun 30, 2024
FIRST LIGHT ASSET MANAGEMENT, LLC2.85%1.71%779,158-164,952-17.47%19,525,699Jun 30, 2024
MANGROVE PARTNERS2.52%1.33%689,521--17,279,396Jun 30, 2024
EVENTIDE ASSET MANAGEMENT, LLC2.08%0.24%568,324141,32433.10%14,242,199Jun 30, 2024
CAMBER CAPITAL MANAGEMENT LP1.83%0.35%500,000500,000100.00%12,530,000Jun 30, 2024
FRANKLIN RESOURCES INC1.70%0.00%465,373--11,662,247Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC1.65%0.00%452,06530,3627.20%11,330,925Jun 30, 2024
MILLENNIUM MANAGEMENT LLC1.37%0.00%373,762-273,363-42.24%9,366,476Jun 30, 2024
5AM VENTURE MANAGEMENT, LLC1.31%2.01%357,733--8,964,789Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP1.23%0.00%335,934-133,926-28.50%8,418,280Jun 30, 2024
ASSENAGON ASSET MANAGEMENT S.A.1.12%0.02%306,63384,79538.22%7,684,223Jun 30, 2024
PRICE T ROWE ASSOCIATES INC /MD/1.10%0.00%300,224128,53574.86%7,525,000Jun 30, 2024

AnaptysBio's largest institutional shareholder is ECOR1 CAPITAL, LLC, holding 27.49% of the company's total share outstanding, currently valued at $188.48M. The top 10 institutional shareholders own together 76.52% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ECOR1 CAPITAL, LLC27.49%5.77%7,521,024--188,476,861Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC4.87%3.40%1,330,879--33,351,828Jun 30, 2024
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.7.92%2.54%2,165,5911,265,891140.70%54,269,710Jun 30, 2024
SATURN V CAPITAL MANAGEMENT LLC0.91%2.36%249,609-336,422-57.41%6,255,202Jun 30, 2024
PALO ALTO INVESTORS LP2.94%2.33%803,6413,7350.47%20,139,243Jun 30, 2024
5AM VENTURE MANAGEMENT, LLC1.31%2.01%357,733--8,964,789Jun 30, 2024
BOXER CAPITAL, LLC4.75%1.72%1,300,000--32,578,000Jun 30, 2024
FIRST LIGHT ASSET MANAGEMENT, LLC2.85%1.71%779,158-164,952-17.47%19,525,699Jun 30, 2024
MANGROVE PARTNERS2.52%1.33%689,521--17,279,396Jun 30, 2024
PARKMAN HEALTHCARE PARTNERS LLC0.94%0.86%256,307256,307100.00%6,423,053Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.57%0.74%155,799154,79915479.90%3,904,323Jun 30, 2024
CAMBER CAPITAL MANAGEMENT LP1.83%0.35%500,000500,000100.00%12,530,000Jun 30, 2024
EVENTIDE ASSET MANAGEMENT, LLC2.08%0.24%568,324141,32433.10%14,242,199Jun 30, 2024
ALPHA DNA INVESTMENT MANAGEMENT LLC0.06%0.15%15,92015,920100.00%398,955Jun 30, 2024
CORTON CAPITAL INC.0.04%0.14%10,52410,524100.00%263,731Jun 30, 2024
UBS OCONNOR LLC0.29%0.12%79,844-3,181-3.83%2,000,891Jun 30, 2024
GREAT POINT PARTNERS LLC0.09%0.12%25,000-951,981-97.44%626,500Jun 30, 2024
ENTRYPOINT CAPITAL, LLC0.01%0.09%2,3902,390100.00%59,893Jun 30, 2024
PLATINUM INVESTMENT MANAGEMENT LTD0.30%0.08%82,40116,24724.56%2,064,969Jun 30, 2024
WOODLINE PARTNERS LP0.92%0.06%252,366-256,473-50.40%6,324,292Jun 30, 2024

The largest AnaptysBio shareholder by % of total assets is ECOR1 CAPITAL, LLC. The company owns 7.52M shares of AnaptysBio (ANAB), representing 5.77% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FMR LLC10.49%0.00%2,870,6182,729,8721939.57%71,937,692Jun 30, 2024
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.7.92%2.54%2,165,5911,265,891140.70%54,269,710Jun 30, 2024
CAMBER CAPITAL MANAGEMENT LP1.83%0.35%500,000500,000100.00%12,530,000Jun 30, 2024
PARKMAN HEALTHCARE PARTNERS LLC0.94%0.86%256,307256,307100.00%6,423,053Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC0.63%0.03%171,593171,593100.00%4,300,119Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.57%0.74%155,799154,79915479.90%3,904,323Jun 30, 2024
EVENTIDE ASSET MANAGEMENT, LLC2.08%0.24%568,324141,32433.10%14,242,199Jun 30, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP0.51%0.02%140,499140,499100.00%3,521,000Jun 30, 2024
NORDEA INVESTMENT MANAGEMENT AB0.50%0.00%135,614135,614100.00%3,356,447Jun 30, 2024
PRICE T ROWE ASSOCIATES INC /MD/1.10%0.00%300,224128,53574.86%7,525,000Jun 30, 2024
ASSENAGON ASSET MANAGEMENT S.A.1.12%0.02%306,63384,79538.22%7,684,223Jun 30, 2024
VANGUARD GROUP INC5.21%0.00%1,424,40670,4035.20%35,695,615Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC0.20%0.01%54,27354,273100.00%1,360,081Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC0.56%0.01%152,70252,50252.40%3,826,712Jun 30, 2024
BLACKROCK INC.6.47%0.00%1,769,94449,8932.90%44,354,795Jun 30, 2024
BANK OF AMERICA CORP /DE/0.38%0.00%104,00149,47690.74%2,606,265Jun 30, 2024
GOLDMAN SACHS GROUP INC0.71%0.00%194,53944,10829.32%4,875,148Jun 30, 2024
JUMP FINANCIAL, LLC0.13%0.02%35,70035,700100.00%894,642Jun 30, 2024
ENSIGN PEAK ADVISORS, INC0.28%0.00%75,75532,31374.38%1,898,420Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC1.65%0.00%452,06530,3627.20%11,330,925Jun 30, 2024

As of Jun 30 2024, AnaptysBio's largest institutional buyer is FMR LLC. The company purchased 2.73M stocks of ANAB, valued at $71.94M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
GREAT POINT PARTNERS LLC0.09%0.12%25,000-951,981-97.44%626,500Jun 30, 2024
POINT72 ASSET MANAGEMENT, L.P.0.07%0.00%17,900-846,200-97.93%448,574Jun 30, 2024
MORGAN STANLEY0.34%0.00%91,768-544,346-85.57%2,299,706Jun 30, 2024
DEEP TRACK CAPITAL, LP----529,452-100.00%-Jun 30, 2024
SATURN V CAPITAL MANAGEMENT LLC0.91%2.36%249,609-336,422-57.41%6,255,202Jun 30, 2024
BLACKSTONE INC.----328,720-100.00%-Jun 30, 2024
MILLENNIUM MANAGEMENT LLC1.37%0.00%373,762-273,363-42.24%9,366,476Jun 30, 2024
STEMPOINT CAPITAL LP----269,548-100.00%-Jun 30, 2024
WOODLINE PARTNERS LP0.92%0.06%252,366-256,473-50.40%6,324,292Jun 30, 2024
STATE STREET CORP3.53%0.00%966,852-240,552-19.92%24,229,311,000Jun 30, 2024
OCTAGON CAPITAL ADVISORS LP----165,000-100.00%-Jun 30, 2024
FIRST LIGHT ASSET MANAGEMENT, LLC2.85%1.71%779,158-164,952-17.47%19,525,699Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP1.23%0.00%335,934-133,926-28.50%8,418,280Jun 30, 2024
HUDSON BAY CAPITAL MANAGEMENT LP0.20%0.01%55,000-77,500-58.49%1,378,300Jun 30, 2024
RAFFERTY ASSET MANAGEMENT, LLC0.18%0.00%49,671-41,023-45.23%1,244,755Jun 30, 2024
FRED ALGER MANAGEMENT, LLC----33,882-100.00%-Jun 30, 2024
BARCLAYS PLC----30,000-100.00%-Jun 30, 2024
UBS GROUP AG0.13%0.00%34,578-29,588-46.11%866,525Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD----28,542-100.00%-Jun 30, 2024
AQR CAPITAL MANAGEMENT LLC----24,328-100.00%-Jun 30, 2024

As of Jun 30 2024, AnaptysBio's biggest institutional seller is GREAT POINT PARTNERS LLC. The company sold -0.95M shares of ANAB, valued at $626.50K.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CAMBER CAPITAL MANAGEMENT LP1.83%0.35%500,000500,000100.00%12,530,000Jun 30, 2024
PARKMAN HEALTHCARE PARTNERS LLC0.94%0.86%256,307256,307100.00%6,423,053Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC0.63%0.03%171,593171,593100.00%4,300,119Jun 30, 2024
NORDEA INVESTMENT MANAGEMENT AB0.50%0.00%135,614135,614100.00%3,356,447Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC0.20%0.01%54,27354,273100.00%1,360,081Jun 30, 2024
JUMP FINANCIAL, LLC0.13%0.02%35,70035,700100.00%894,642Jun 30, 2024
Y-INTERCEPT (HONG KONG) LTD0.07%0.03%20,45520,455100.00%512,602Jun 30, 2024
ALPHA DNA INVESTMENT MANAGEMENT LLC0.06%0.15%15,92015,920100.00%398,955Jun 30, 2024
ENGINEERS GATE MANAGER LP0.04%0.01%12,08212,082100.00%302,775Jun 30, 2024
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.0.04%0.00%11,63211,632100.00%291,012Jun 30, 2024
CRESSET ASSET MANAGEMENT, LLC0.04%0.00%11,04711,047100.00%276,837Jun 30, 2024
COREBRIDGE FINANCIAL, INC.0.04%0.00%10,52610,526100.00%263,782Jun 30, 2024
CORTON CAPITAL INC.0.04%0.14%10,52410,524100.00%263,731Jun 30, 2024
STATE OF WISCONSIN INVESTMENT BOARD0.03%0.00%9,3309,330100.00%233,810Jun 30, 2024
ENTRYPOINT CAPITAL, LLC0.01%0.09%2,3902,390100.00%59,893Jun 30, 2024
POINT72 ASIA (SINGAPORE) PTE. LTD.0.00%0.00%902902100.00%22,604Jun 30, 2024
POINT72 (DIFC) LTD0.00%0.00%785785100.00%19,672Jun 30, 2024
COPPELL ADVISORY SOLUTIONS LLC0.00%0.00%714714100.00%17,893Jun 30, 2024
MACROVIEW INVESTMENT MANAGEMENT LLC0.00%0.01%313313100.00%7,844Jun 30, 2024
NVERSES CAPITAL, LLC0.00%0.00%200200100.00%5,012Jun 30, 2024
SMARTLEAF ASSET MANAGEMENT LLC0.00%0.00%8989100.00%2,207Jun 30, 2024
SRS CAPITAL ADVISORS, INC.0.00%0.00%6161100.00%1,529Jun 30, 2024
FORTITUDE FAMILY OFFICE, LLC0.00%0.00%3131100.00%777Jun 30, 2024
ROTHSCHILD INVESTMENT LLC--55100.00%125Jun 30, 2024

AnaptysBio's largest new institutional shareholder by number of shares is CAMBER CAPITAL MANAGEMENT LP, purchased 500.00K shares, valued at $12.53M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
DEEP TRACK CAPITAL, LP----529,452-100.00%-Jun 30, 2024
BLACKSTONE INC.----328,720-100.00%-Jun 30, 2024
STEMPOINT CAPITAL LP----269,548-100.00%-Jun 30, 2024
OCTAGON CAPITAL ADVISORS LP----165,000-100.00%-Jun 30, 2024
FRED ALGER MANAGEMENT, LLC----33,882-100.00%-Jun 30, 2024
BARCLAYS PLC----30,000-100.00%-Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD----28,542-100.00%-Jun 30, 2024
AQR CAPITAL MANAGEMENT LLC----24,328-100.00%-Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC----18,671-100.00%-Jun 30, 2024
BALYASNY ASSET MANAGEMENT L.P.----15,746-100.00%-Jun 30, 2024
SHERBROOKE PARK ADVISERS LLC----15,272-100.00%-Jun 30, 2024
VERITION FUND MANAGEMENT LLC----13,472-100.00%-Jun 30, 2024
VIRTU FINANCIAL LLC----9,850-100.00%-Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----9,232-100.00%-Jun 30, 2024
WALLEYE CAPITAL LLC----9,015-100.00%-Jun 30, 2024
AQUATIC CAPITAL MANAGEMENT LLC----7,600-100.00%-Jun 30, 2024
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC----1,688-100.00%-Jun 30, 2024
METROPOLITAN LIFE INSURANCE CO/NY----1,211-100.00%-Jun 30, 2024
QUEST PARTNERS LLC----586-100.00%-Jun 30, 2024
STEWARD PARTNERS INVESTMENT ADVISORY, LLC----150-100.00%-Jun 30, 2024
SIMPLEX TRADING, LLC----100-100.00%-Jun 30, 2024
AVION WEALTH----36-100.00%-Jun 30, 2024
WESTEND CAPITAL MANAGEMENT, LLC----29-100.00%-Jun 30, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC----4-100.00%-Jun 30, 2024

AnaptysBio's largest sold out institutional shareholder by shares sold is DEEP TRACK CAPITAL, LP, sold -0.53M shares, valued at -, as of undefined.

AnaptysBio Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
TEKLA HEALTHCARE INVESTORS0.10%82,022--Mar 31, 2024
DELAWARE GROUP EQUITY FUNDS IV0.08%93,732--Mar 28, 2024
TEKLA LIFE SCIENCES INVESTORS0.08%36,239--Mar 31, 2024
T. Rowe Price Small-Cap Stock Fund, Inc.0.06%202,487--Mar 31, 2024
FIDELITY ADVISOR SERIES VII0.05%442,225--Jan 31, 2024
T. Rowe Price Health Sciences Fund, Inc.0.04%131,270-51,760-28.28%Mar 31, 2024
T. Rowe Price New Horizons Fund, Inc.0.04%188,066--Mar 31, 2024
ALGER FUNDS0.03%30,000--Jan 31, 2024
VARIABLE INSURANCE PRODUCTS FUND IV0.02%66,113--Mar 31, 2024
VANGUARD VALLEY FORGE FUNDS0.02%12,700--Mar 31, 2024
Federated Hermes Equity Funds0.02%458,545--Jan 31, 2024
SMALLCAP WORLD FUND INC0.02%1,256,000--Mar 31, 2024
Humankind Benefit Corp0.02%3447929.81%Dec 31, 2023
FRANKLIN STRATEGIC SERIES0.02%127,52322,06020.92%Jan 31, 2024
Federated Hermes MDT Series0.01%35,552--Jan 31, 2024
T. Rowe Price Equity Funds, Inc.0.01%108,261--Mar 31, 2024
FIDELITY SECURITIES FUND0.01%857,834--Jan 31, 2024
FIDELITY DESTINY PORTFOLIOS0.01%18,000--Mar 31, 2024
AIM INTERNATIONAL MUTUAL FUNDS (INVESCO INTERNATIONAL MUTUAL FUNDS)0.01%211,559--Jan 31, 2024
QUANTITATIVE MASTER SERIES LLC0.01%33,419-2,126-5.98%Mar 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.00%2,843--Mar 31, 2024
JAMES ADVANTAGE FUNDS0.00%10,132--Dec 31, 2023
Fidelity Central Investment Portfolios LLC0.00%226,024--Feb 29, 2024
FEDERATED HERMES INSURANCE SERIES0.00%18,700--Mar 31, 2024
T. Rowe Price Equity Series, Inc.0.00%6,300-2,230-26.14%Mar 31, 2024
FORUM FUNDS II0.00%3,400--Jan 31, 2024
JNL VARIABLE FUND LLC0.00%19,184--Mar 31, 2020
FIDELITY CAPITAL TRUST0.00%36,935--Jan 31, 2024
TIAA SEPARATE ACCOUNT VA 10.00%679--Mar 31, 2024
ETFis Series Trust I0.00%4,310-1,013-19.03%Jan 31, 2024
VANGUARD INDEX FUNDS0.00%1,163,099-291,606-20.05%Mar 31, 2024
AMG Funds I0.00%4,736--Jan 31, 2024
UBS FUNDS0.00%10,674--Mar 31, 2024
FIDELITY SELECT PORTFOLIOS0.00%139,628-62,000-30.75%Feb 29, 2024
Nushares ETF Trust0.00%15,251--Jan 31, 2024
Fidelity Commonwealth Trust II0.00%13,080--Aug 31, 2023
VANGUARD HORIZON FUNDS0.00%45,021--Mar 31, 2024
VARIABLE INSURANCE PRODUCTS FUND III0.00%15,252--Mar 31, 2024
JPMORGAN INSURANCE TRUST0.00%23,679-1,021-4.13%Mar 31, 2023
FIDELITY COMMONWEALTH TRUST0.00%5,651--Feb 29, 2024
AMG FUNDS III0.00%8,994--Mar 28, 2024
FIDELITY MT VERNON STREET TRUST0.00%45,411--Feb 29, 2024
ALPS ETF Trust0.00%19,4587033.75%Feb 29, 2024
SCHWAB CAPITAL TRUST0.00%50,625--Jan 31, 2024
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.00%4,446--Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%188,0812,3821.28%Feb 29, 2024
MFS VARIABLE INSURANCE TRUST III0.00%14,409--Mar 31, 2024
TIMOTHY PLAN0.00%3,932--Mar 31, 2024
VICTORY PORTFOLIOS0.00%25,470-2,880-10.16%Mar 31, 2024
Legg Mason ETF Investment Trust0.00%1,555--Mar 31, 2024
VANGUARD QUANTITATIVE FUNDS0.00%3,323--Mar 31, 2024
PFM Multi-Manager Series Trust0.00%500--Dec 31, 2023
Voya INVESTORS TRUST0.00%33,441--Mar 31, 2024
Calvert Variable Products, Inc.0.00%1,512--Mar 31, 2024
USAA MUTUAL FUNDS TRUST0.00%111,785-28,482-20.31%Jan 31, 2024
NEW COVENANT FUNDS0.00%1,908--Dec 31, 2023
ProFunds0.00%4,7514,5932906.96%Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%11,911-836-6.56%Mar 31, 2024
FIDELITY COVINGTON TRUST0.00%6,923-2,113-23.38%Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%369,143-6,970-1.85%Jan 31, 2024
Voya PARTNERS INC0.00%28,649--Mar 31, 2024
AdvisorShares Trust0.00%1,366--Mar 28, 2024
Principal Exchange-Traded Funds0.00%4,135-340-7.60%Mar 31, 2024
SunAmerica Specialty Series0.00%177--Apr 30, 2021
Direxion Shares ETF Trust0.00%48,920--Jan 31, 2024
Federated Hermes Adviser Series0.00%1,580--Mar 31, 2024
Dimensional ETF Trust0.00%106,760-55,234-34.10%Jan 31, 2024
PUTNAM ASSET ALLOCATION FUNDS0.00%7,837--Mar 31, 2024
Dunham Funds0.00%15,929--Jan 31, 2024
Voya VARIABLE PORTFOLIOS INC0.00%6,240-1,760-22.00%Mar 31, 2024
Global X Funds0.00%8,602--Jan 31, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%947--Mar 31, 2024
Victory Portfolios II0.00%9,685--Mar 31, 2024
VANGUARD WORLD FUND0.00%45,061-13,627-23.22%Feb 29, 2024
MASSMUTUAL PREMIER FUNDS0.00%5,102--Dec 31, 2023
North Square Investments Trust0.00%1,720--Jan 31, 2024
GPS Funds I0.00%912--Mar 31, 2024
SCHWAB STRATEGIC TRUST0.00%96,8523,2623.49%Feb 29, 2024
SA FUNDS INVESTMENT TRUST0.00%2,569--Mar 31, 2024
NORTHERN FUNDS0.00%19,5415522.91%Mar 28, 2024
INVESCO EXCHANGE-TRADED FUND TRUST0.00%10,497--Jan 31, 2024
Meeder Funds0.00%549--Mar 31, 2024
TIAA-CREF LIFE FUNDS0.00%305--Mar 31, 2024
THRIVENT SERIES FUND INC0.00%12,212--Mar 28, 2024
Federated Hermes Global Allocation Fund0.00%1,075--Feb 29, 2024
MUTUAL FUND SERIES TRUST0.00%427,000--Mar 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%6,014--Mar 31, 2024
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST0.00%4,571--Dec 31, 2023
VARIABLE INSURANCE PRODUCTS FUND II0.00%1,017--Mar 31, 2024
Forethought Variable Insurance Trust0.00%327--Mar 28, 2024
AMERICAN CENTURY ETF TRUST0.00%8,408-2,598-23.61%Feb 29, 2024
THRIVENT MUTUAL FUNDS0.00%5,704--Mar 28, 2024
T. Rowe Price Index Trust, Inc.0.00%1,19616115.56%Mar 31, 2024
iSHARES TRUST0.00%872,718-60,092-6.44%Mar 31, 2024
EQ ADVISORS TRUST0.00%62,237-3,624-5.50%Mar 31, 2024
MAINSTAY FUNDS TRUST0.00%9,731--Jan 31, 2024
Columbia Funds Variable Series Trust II0.00%1,471--Mar 31, 2024
OHIO NATIONAL FUND INC0.00%867--Mar 31, 2024
GLENMEDE FUND INC0.00%375--Jan 31, 2024
VANGUARD SCOTTSDALE FUNDS0.00%85,31210,70914.35%Feb 29, 2024

AnaptysBio's largest mutual fund holder by % of total assets is "TEKLA HEALTHCARE INVESTORS", owning 82.02K shares, compromising 0.10% of its total assets.

AnaptysBio Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 24136-1.45%
31 Mar, 2413812.20%
31 Dec, 231231.65%
30 Sep, 23121-0.82%
30 Jun, 231224.27%
31 Mar, 23117-1.68%
31 Dec, 221194.39%
30 Sep, 22114-8.80%
30 Jun, 22125-3.85%
31 Mar, 22130-4.41%
31 Dec, 211367.09%
30 Sep, 211273.25%
30 Jun, 21123-8.21%
31 Mar, 21134-0.74%
31 Dec, 201353.05%
30 Sep, 201316.50%
30 Jun, 201231.65%
31 Mar, 20121-11.68%
31 Dec, 191376.20%
30 Sep, 19129-2.27%
30 Jun, 19132-4.35%
31 Mar, 191387.81%
31 Dec, 18128-13.51%
30 Sep, 1814811.28%
30 Jun, 18133-6.99%
31 Mar, 1814317.21%
31 Dec, 1712274.29%
30 Sep, 177034.62%
30 Jun, 17521.96%
31 Mar, 1751-

As of 30 Jun 24, 136 institutions are holding AnaptysBio's shares, representing a decrease of -1.45% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 2429,760,5721.99%
31 Mar, 2429,181,194-3.19%
31 Dec, 2330,143,373-0.47%
30 Sep, 2330,284,9850.30%
30 Jun, 2330,195,162-2.60%
31 Mar, 2331,002,778-5.86%
31 Dec, 2232,932,8481.15%
30 Sep, 2232,557,7364.47%
30 Jun, 2231,164,5024.83%
31 Mar, 2229,727,3287.15%
31 Dec, 2127,744,5830.53%
30 Sep, 2127,597,098-0.63%
30 Jun, 2127,773,221-4.94%
31 Mar, 2129,215,4354.69%
31 Dec, 2027,906,529-4.16%
30 Sep, 2029,117,584-2.93%
30 Jun, 2029,996,071-3.94%
31 Mar, 2031,226,84510.37%
31 Dec, 1928,291,996-2.58%
30 Sep, 1929,041,995-3.77%
30 Jun, 1930,181,1373.65%
31 Mar, 1929,117,8340.53%
31 Dec, 1828,963,0951.16%
30 Sep, 1828,630,43314.70%
30 Jun, 1824,960,4202.54%
31 Mar, 1824,342,4932.39%
31 Dec, 1723,774,84834.10%
30 Sep, 1717,729,63329.38%
30 Jun, 1713,704,043-2.20%
31 Mar, 1714,011,950-

AnaptysBio (ANAB) has 29.76M shares outstanding as of 30 Jun 24, up 1.99% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 24108.79%0.92%
31 Mar, 24108.88%0.87%
31 Dec, 23111.96%0.86%
30 Sep, 23114.08%0.89%
30 Jun, 23113.39%0.92%
31 Mar, 23110.91%0.81%
31 Dec, 22116.93%0.88%
30 Sep, 22115.09%0.94%
30 Jun, 22110.50%0.96%
31 Mar, 22107.27%1.05%
31 Dec, 21101.14%1.00%
30 Sep, 21100.59%0.98%
30 Jun, 21101.40%0.89%
31 Mar, 21106.78%1.02%
31 Dec, 20102.21%0.90%
30 Sep, 20106.60%0.88%
30 Jun, 20109.96%0.84%
31 Mar, 20114.54%1.06%
31 Dec, 19104.19%0.90%
30 Sep, 19107.33%0.86%
30 Jun, 19111.67%0.96%
31 Mar, 19107.92%0.92%
31 Dec, 18108.29%0.77%
30 Sep, 18118.57%1.09%
30 Jun, 18104.30%1.00%
31 Mar, 18102.28%0.71%
31 Dec, 17120.18%1.59%
30 Sep, 1786.99%1.90%
30 Jun, 1767.60%0.81%
31 Mar, 1791.61%-

As of 30 Jun 24, AnaptysBio is held by 108.79% institutional shareholders, representing a 0.92% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 24673.08%
31 Mar, 246541.30%
31 Dec, 2346-4.17%
30 Sep, 2348-7.69%
30 Jun, 23524.00%
31 Mar, 23502.04%
31 Dec, 2249-
30 Sep, 2249-14.04%
30 Jun, 22579.62%
31 Mar, 2252-17.46%
31 Dec, 216340.00%
30 Sep, 21459.76%
30 Jun, 2141-22.64%
31 Mar, 2153-8.62%
31 Dec, 205818.37%
30 Sep, 2049-9.26%
30 Jun, 2054-8.47%
31 Mar, 2059-31.40%
31 Dec, 198622.86%
30 Sep, 1970-16.67%
30 Jun, 198412.00%
31 Mar, 197513.64%
31 Dec, 1866-19.51%
30 Sep, 18822.50%
30 Jun, 1880-1.23%
31 Mar, 1881-11.96%
31 Dec, 179267.27%
30 Sep, 175571.88%
30 Jun, 1732-37.25%
31 Mar, 1751-

67 institutional shareholders have increased their position in ANAB stock as of 30 Jun 24 compared to 65 in the previous quarter (a 3.08% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 244512.50%
31 Mar, 2440-9.09%
31 Dec, 234415.79%
30 Sep, 23388.57%
30 Jun, 2335-2.78%
31 Mar, 2336-2.70%
31 Dec, 22372.78%
30 Sep, 2236-7.69%
30 Jun, 2239-22.00%
31 Mar, 225016.28%
31 Dec, 21432.38%
30 Sep, 2142-14.29%
30 Jun, 214919.51%
31 Mar, 2141-6.82%
31 Dec, 2044-13.73%
30 Sep, 205113.33%
30 Jun, 204521.62%
31 Mar, 203785.00%
31 Dec, 1920-39.39%
30 Sep, 193337.50%
30 Jun, 1924-20.00%
31 Mar, 1930-16.67%
31 Dec, 18369.09%
30 Sep, 1833-2.94%
30 Jun, 1834-19.05%
31 Mar, 1842121.05%
31 Dec, 171990.00%
30 Sep, 1710-16.67%
30 Jun, 1712-
31 Mar, 17--

45 institutional shareholders have reduced their position in ANAB stock as of 30 Jun 24 compared to 40 in the previous quarter (a 12.50% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 24136-1.45%29,760,5721.99%108.79%0.92%673.08%4512.50%
31 Mar, 2413812.20%29,181,194-3.19%108.88%0.87%6541.30%40-9.09%
31 Dec, 231231.65%30,143,373-0.47%111.96%0.86%46-4.17%4415.79%
30 Sep, 23121-0.82%30,284,9850.30%114.08%0.89%48-7.69%388.57%
30 Jun, 231224.27%30,195,162-2.60%113.39%0.92%524.00%35-2.78%
31 Mar, 23117-1.68%31,002,778-5.86%110.91%0.81%502.04%36-2.70%
31 Dec, 221194.39%32,932,8481.15%116.93%0.88%49-372.78%
30 Sep, 22114-8.80%32,557,7364.47%115.09%0.94%49-14.04%36-7.69%
30 Jun, 22125-3.85%31,164,5024.83%110.50%0.96%579.62%39-22.00%
31 Mar, 22130-4.41%29,727,3287.15%107.27%1.05%52-17.46%5016.28%
31 Dec, 211367.09%27,744,5830.53%101.14%1.00%6340.00%432.38%
30 Sep, 211273.25%27,597,098-0.63%100.59%0.98%459.76%42-14.29%
30 Jun, 21123-8.21%27,773,221-4.94%101.40%0.89%41-22.64%4919.51%
31 Mar, 21134-0.74%29,215,4354.69%106.78%1.02%53-8.62%41-6.82%
31 Dec, 201353.05%27,906,529-4.16%102.21%0.90%5818.37%44-13.73%
30 Sep, 201316.50%29,117,584-2.93%106.60%0.88%49-9.26%5113.33%
30 Jun, 201231.65%29,996,071-3.94%109.96%0.84%54-8.47%4521.62%
31 Mar, 20121-11.68%31,226,84510.37%114.54%1.06%59-31.40%3785.00%
31 Dec, 191376.20%28,291,996-2.58%104.19%0.90%8622.86%20-39.39%
30 Sep, 19129-2.27%29,041,995-3.77%107.33%0.86%70-16.67%3337.50%
30 Jun, 19132-4.35%30,181,1373.65%111.67%0.96%8412.00%24-20.00%
31 Mar, 191387.81%29,117,8340.53%107.92%0.92%7513.64%30-16.67%
31 Dec, 18128-13.51%28,963,0951.16%108.29%0.77%66-19.51%369.09%
30 Sep, 1814811.28%28,630,43314.70%118.57%1.09%822.50%33-2.94%
30 Jun, 18133-6.99%24,960,4202.54%104.30%1.00%80-1.23%34-19.05%
31 Mar, 1814317.21%24,342,4932.39%102.28%0.71%81-11.96%42121.05%
31 Dec, 1712274.29%23,774,84834.10%120.18%1.59%9267.27%1990.00%
30 Sep, 177034.62%17,729,63329.38%86.99%1.90%5571.88%10-16.67%
30 Jun, 17521.96%13,704,043-2.20%67.60%0.81%32-37.25%12-
31 Mar, 1751-14,011,950-91.61%-51---

AnaptysBio Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 16, 2024Lizzul Paul F.officer Chief Medical OfficerS-SaleSell2,000$40.00$80.00K11,618
Aug 16, 2024EcoR1 Capital, LLC10 percent owner-P-PurchaseBuy273,972$36.50$10.00M7,794,996
Jul 19, 2024Lizzul Paul F.officer Chief Medical OfficerS-SaleSell1,500$35.00$52.50K11,618
Jul 17, 2024RENTON HOLLINGSdirector-S-SaleSell7,103$30.50$216.67K4,847
Jul 17, 2024RENTON HOLLINGSdirector-S-SaleSell2,897$30.98$89.75K1,950
Jun 24, 2024FENTON DENNIS Mdirector-S-SaleSell1,950$23.17$45.18K1,950

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 16, 2024EcoR1 Capital, LLC10 percent owner-P-PurchaseBuy273,972$36.50$10.00M7,794,996

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 16, 2024Lizzul Paul F.officer Chief Medical OfficerM-ExemptSell2,000$18.50$37.00K86,500
Aug 16, 2024Lizzul Paul F.officer Chief Medical OfficerS-SaleSell2,000$40.00$80.00K11,618
Jul 19, 2024Lizzul Paul F.officer Chief Medical OfficerM-ExemptSell1,500$18.50$27.75K88,500
Jul 19, 2024Lizzul Paul F.officer Chief Medical OfficerS-SaleSell1,500$35.00$52.50K11,618
Jul 17, 2024RENTON HOLLINGSdirector-M-ExemptSell10,000$6.93$69.30K30,925
Jul 17, 2024RENTON HOLLINGSdirector-S-SaleSell7,103$30.50$216.67K4,847
Jul 17, 2024RENTON HOLLINGSdirector-S-SaleSell2,897$30.98$89.75K1,950
Jun 24, 2024FENTON DENNIS Mdirector-S-SaleSell1,950$23.17$45.18K1,950
Jun 18, 2024FENTON DENNIS Mdirector-M-ExemptSell3,900---
Jun 18, 2024Marquet Magdadirector-M-ExemptSell3,900---

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 16, 2024Lizzul Paul F.officer Chief Medical OfficerM-ExemptSell2,000$18.50$37.00K86,500
Aug 16, 2024Lizzul Paul F.officer Chief Medical OfficerM-ExemptBuy2,000$18.50$37.00K13,618
Aug 16, 2024Lizzul Paul F.officer Chief Medical OfficerS-SaleSell2,000$40.00$80.00K11,618
Aug 16, 2024EcoR1 Capital, LLC10 percent owner-P-PurchaseBuy273,972$36.50$10.00M7,794,996
Jul 24, 2024Faga Danieldirector, officer CEOA-AwardBuy160,000--160,000
Jul 24, 2024Lizzul Paul F.officer Chief Medical OfficerA-AwardBuy50,000--50,000
Jul 24, 2024MULROY DENNISofficer CHIEF FINANCIAL OFFICERA-AwardBuy20,000--20,000
Jul 24, 2024LOUMEAU ERIC Jofficer CHIEF LEGAL OFFICERA-AwardBuy20,000--20,000
Jul 19, 2024Lizzul Paul F.officer Chief Medical OfficerM-ExemptSell1,500$18.50$27.75K88,500
Jul 19, 2024Lizzul Paul F.officer Chief Medical OfficerM-ExemptBuy1,500$18.50$27.75K13,118
Jul 19, 2024Lizzul Paul F.officer Chief Medical OfficerS-SaleSell1,500$35.00$52.50K11,618
Jul 17, 2024RENTON HOLLINGSdirector-M-ExemptSell10,000$6.93$69.30K30,925
Jul 17, 2024RENTON HOLLINGSdirector-M-ExemptBuy10,000$6.93$69.30K11,950
Jul 17, 2024RENTON HOLLINGSdirector-S-SaleSell7,103$30.50$216.67K4,847
Jul 17, 2024RENTON HOLLINGSdirector-S-SaleSell2,897$30.98$89.75K1,950
Jun 24, 2024FENTON DENNIS Mdirector-S-SaleSell1,950$23.17$45.18K1,950
Jun 18, 2024FENTON DENNIS Mdirector-M-ExemptBuy3,900--3,900
Jun 18, 2024FENTON DENNIS Mdirector-M-ExemptSell3,900---
Jun 18, 2024Marquet Magdadirector-M-ExemptBuy3,900--3,900
Jun 18, 2024Marquet Magdadirector-M-ExemptSell3,900---

The last insider sell of AnaptysBio's stock was made by Lizzul Paul F. on Aug 16 2024, selling 2,000 shares at $18.50 per share (valued at $37.00K). The last insider buy of ANAB was made by EcoR1 Capital, LLC on Aug 16 2024, buying 273,972 shares at $36.50 per share (worth $10.00M).

AnaptysBio Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 202487114.29%
Q2 202471070.00%
Q1 20242714192.86%
Q4 2023-1-
Q3 20237887.50%
Q2 20234--
Q1 202322--
Q3 202231300.00%
Q2 202284200.00%
Q1 202213--
Q4 2021131586.67%
Q3 202111100.00%
Q2 202171700.00%
Q1 2021172850.00%
Q4 20202366.67%
Q3 20203--
Q1 202082400.00%
Q4 201962300.00%
Q3 201931300.00%
Q2 201921020.00%

8 total buy trades, and 7 total sell trades (buy/sell ratio of 1.14%) were made by AnaptysBio's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 20241425.00%
Q2 2024-3-
Q1 2024-8-
Q4 2023-1-
Q3 2023-5-
Q2 2023---
Q1 2023---
Q3 2022-1-
Q2 20222450.00%
Q1 2022---
Q4 2021-8-
Q3 2021---
Q2 20216--
Q1 202131300.00%
Q4 2020---
Q3 2020---
Q1 2020---
Q4 20191--
Q3 2019---
Q2 2019-8-

As of Q3 2024, Insider owners conducted 1 open market buy trades and 4 open market sell trades of AnaptysBio's stocks.

AnaptysBio Peer Ownership


TickerCompany
CTMXCytomX Therapeutics, Inc.
DCPHDeciphera Pharmaceuticals, Inc.
CRNXCrinetics Pharmaceuticals, Inc.
RYTMRhythm Pharmaceuticals, Inc.
KURAKura Oncology, Inc.

ANAB Ownership FAQ


AnaptysBio is owned by institutional shareholders (108.79%), insiders (1.75%), and public (-10.54%). The largest institutional shareholder of AnaptysBio is ECOR1 CAPITAL, LLC (27.49% of total shares) and the top mutual fund owner is TEKLA HEALTHCARE INVESTORS (0.10% of total shares).

AnaptysBio's major institutional shareholders are ECOR1 CAPITAL, LLC, FMR LLC, FRAZIER LIFE SCIENCES MANAGEMENT, L.P., BLACKROCK INC., and VANGUARD GROUP INC. The top five shareholders own together 57.58% of the company's share outstanding.

As of Jun 2024, there are 136 institutional shareholders of AnaptysBio.

ECOR1 CAPITAL, LLC owns 7.52M shares of AnaptysBio, representing 27.49% of the company's total shares outstanding, valued at $188.48M (as of Jun 2024).

As of Jun 2024, FMR LLC holds 2.87M shares of AnaptysBio (ANAB), compromising 10.49% of the company, valued at $71.94M.

FRAZIER LIFE SCIENCES MANAGEMENT, L.P is the third largest holder of AnaptysBio. The company owns 2.17M of the company's shares outstanding (worth $54.27M).